| 000 | 01779 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516102537.0 | ||
| 264 | 0 | _c20121203 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0038563 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Serres, Gaston | |
| 245 | 0 | 0 |
_aShort and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine. _h[electronic resource] |
| 260 |
_bPloS one _c2012 |
||
| 300 |
_ae38563 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Personnel |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza A Virus, H1N1 Subtype _ximmunology |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPandemics |
| 650 | 0 | 4 |
_aParesthesia _xchemically induced |
| 700 | 1 | _aGariépy, Marie-Claude | |
| 700 | 1 | _aColeman, Brenda | |
| 700 | 1 | _aRouleau, Isabelle | |
| 700 | 1 | _aMcNeil, Shelly | |
| 700 | 1 | _aBenoît, Mélanie | |
| 700 | 1 | _aMcGeer, Allison | |
| 700 | 1 | _aAmbrose, Ardith | |
| 700 | 1 | _aNeedham, Judy | |
| 700 | 1 | _aBergeron, Chantal | |
| 700 | 1 | _aGrenier, Cynthia | |
| 700 | 1 | _aSleigh, Kenna | |
| 700 | 1 | _aKallos, Arlene | |
| 700 | 1 | _aOuakki, Manale | |
| 700 | 1 | _aOuhoummane, Najwa | |
| 700 | 1 | _aStiver, Grant | |
| 700 | 1 | _aValiquette, Louis | |
| 700 | 1 | _aMcCarthy, Anne | |
| 700 | 1 | _aBettinger, Julie | |
| 773 | 0 |
_tPloS one _gvol. 7 _gno. 7 _gp. e38563 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0038563 _zAvailable from publisher's website |
| 999 |
_c21950275 _d21950275 |
||